Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd3+ Strategy for in Vivo Tumor-Targeted Imaging

详细信息    查看全文

• 作者：Hongli Du ; Jiani Yu ; Dongcai Guo ; Weitao Yang ; Jun Wang ; Bingbo Zhang
• 刊名：Langmuir
• 出版年：2016
• 出版时间：February 2, 2016
• 年：2016
• 卷：32
• 期：4
• 页码：1155-1165
• 全文大小：620K
• ISSN：1520-5827

文摘

Gd³⁺-ion-doped upconversion nanoparticles (UCNPs), integrating the advantages of upconversion luminescence and magnetic resonance imaging (MRI) modalities, are capturing increasing attention because they are promising to improve the accuracy of diagnosis. The embedded Gd³⁺ ions in UCNPs, however, have an indistinct MRI enhancement owing to the inefficient exchange of magnetic fields with the surrounding water protons. In this study, a novel approach is developed to improve the MR imaging sensitivity of Gd³⁺-ion-doped UCNPs. Bovine serum albumin (BSA) bundled with DTPA-Gd³⁺ (DTPA^Gd) is synthesized both as the MR imaging sensitivity synergist and phase-transfer ligand for the surface engineering of UCNPs. The external Gd³⁺ ion attachment strategy is found to significant improve the MR imaging sensitivity of Gd³⁺-ion-doped UCNPs. The relaxivity analysis shows that UCNPs@BSA·DTPA^Gd exhibit higher relaxivity values than do UCNPs@BSA without DTPA^Gd moieties. Another relaxivity study discloses a striking message that the relaxivity value does not always reflect the realistic MRI enhancement capability. The high concentration of Gd³⁺-ion-containing UCNPs with further surface-engineered BSA·DTPA^Gd (denoted as UCNPs_–H@BSA·DTPA^Gd) exhibits a more pronounced MRI enhancement capability compared to the other two counterparts [UCNPs_–N@BSA·DTPA^Gd and UCNPs_–L@BSA·DTPA^Gd (_?N and _–L are denoted as zero and low concentrations of Gd³⁺ ion doping, respectively)], even though it holds the lowest r₁ of 1.56 s^–1 per mmol L^–1 of Gd³⁺. The physicochemical properties of UCNPs are essentially maintained after BSA·DTPA^Gd surface decoration with good colloidal stability, in addition to improving the MR imaging sensitivity. In vivo T₁-weighted MRI shows potent tumor-enhanced MRI with UCNPs_–H@BSA·DTPA^Gd. An in vivo biodistribution study indicates that it is gradually excreted from the body via hepatobiliary and renal processing with no obvious toxicity. It could therefore be concluded, with improved MR imaging sensitivity by an internal and external incorporation of Gd³⁺ strategy, that UCNPs_–H@BSA·DTPA^Gd presents great potential as an alternative in tumor-targeted MR imaging.